Lipid hydroperoxide stimulates retinal neovascularization in rabbit retina through expression of tumor necrosis factor-a, vascular endothelial growth factor and platelet-derived growth factor

[1]  R. Browne,et al.  Lipid hydroperoxide-induced tumor necrosis factor (TNF)-α, vascular endothelial growth factor and neovascularization in the rabbit cornea: effect of TNF inhibition , 1997, Angiogenesis.

[2]  K. Plate,et al.  Angiogenesis in Embryos and Ischemic Diseases , 1997, Thrombosis and Haemostasis.

[3]  P. Campochiaro,et al.  Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. , 1997, The American journal of pathology.

[4]  P. Carmeliet,et al.  Insights in Vessel Development and Vascular Disorders Using Targeted Inactivation and Transfer of Vascular Endothelial Growth Factor, the Tissue Factor Receptor, and the Plasminogen System , 1997, Annals of the New York Academy of Sciences.

[5]  Mayumi Ono,et al.  Induction of Vascular Endothelial Growth Factor by Tumor Necrosis Factor α in Human Glioma Cells , 1996, The Journal of Biological Chemistry.

[6]  E. Voest,et al.  Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. , 1996, The Journal of clinical investigation.

[7]  A. Hofman,et al.  Age-related macular degeneration and smoking. The Rotterdam Study. , 1996 .

[8]  H. Dvorak,et al.  Correlation of vascular permeability factor/vascular endothelial growth factor with extraretinal neovascularization in the rat. , 1996, Archives of ophthalmology.

[9]  P. Colville-Nash,et al.  THE ROLE OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN A MURINE CHRONIC GRANULOMATOUS TISSUE AIR POUCH MODEL OF ANGIOGENESIS , 1996, The Journal of pathology.

[10]  R. Håkanson,et al.  The contribution of nitric oxide to endotoxin‐induced ocular inflammation: interaction with sensory nerve fibres , 1996, British journal of pharmacology.

[11]  C. Hariton,et al.  Additive effect of nitric oxide and prostaglandin-E2 synthesis inhibitors in endotoxin-induced uveitis in the rabbit , 1996, Inflammation Research.

[12]  David A. Cheresh,et al.  Definition of Two Angiogenic Pathways by Distinct αv Integrins , 1995, Science.

[13]  W. Christen.  Dietary carotenoids, vitamins A, C, and E, and macular degeneration. , 1995, JAMA.

[14]  G. Pierce,et al.  Platelet-derived growth factor BB induces functional vascular anastomoses in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[15]  T. Colbert,et al.  TNF-alpha stimulation of fibroblast proliferation. Dependence on platelet-derived growth factor (PDGF) secretion and alteration of PDGF receptor expression. , 1995, Journal of immunology.

[16]  M. Luster,et al.  Iron and reactive oxygen species in the asbestos-induced tumor necrosis factor-alpha response from alveolar macrophages. , 1995, American journal of respiratory cell and molecular biology.

[17]  M. Longaker,et al.  Regulation of Vascular Endothelial Growth Factor Expression in Cultured Keratinocytes. , 1995, The Journal of Biological Chemistry.

[18]  M. Matsumoto,et al.  Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[19]  A. Griesmacher,et al.  Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus. , 1995, The American journal of medicine.

[20]  N. Voelkel,et al.  Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. , 1995, The Journal of clinical investigation.

[21]  D. Marmé,et al.  Hypoxia-induced transcription of the vascular endothelial growth factor gene is independent of functional AP-1 transcription factor. , 1995, Biochemical and biophysical research communications.

[22]  J. Spranger,et al.  [TNF-alpha level in the vitreous body. Increase in neovascular eye diseases and proliferative diabetic retinopathy]. , 1995, Medizinische Klinik.

[23]  A. Harris,et al.  Different angiogenic pathways characterize superficial and invasive bladder cancer. , 1995, Cancer research.

[24]  Lois E. H. Smith,et al.  Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[25]  G. Breier,et al.  Hypoxia and platelet‐derived growth factor‐BB synergistically upregulate the expression of vascular endothelial growth factor in vascular smooth muscle cells , 1995, FEBS letters.

[26]  R. Spengler,et al.  Tumor necrosis factor-α: presynaptic sensitivity is modified after antidepressant drug administration , 1994, Brain Research.

[27]  L. Aiello,et al.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. , 1994, The New England journal of medicine.

[28]  M. Boulton,et al.  Oxygen regulation of TGF-beta 1 mRNA in human hepatoma (Hep G2) cells. , 1994, Biochemistry and molecular biology international.

[29]  Joan W. Miller,et al.  Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. , 1994, American journal of ophthalmology.

[30]  F. Walther,et al.  Plasma Xanthine Oxidase Activity and Lipid Hydroperoxide Levels in Preterm Infants , 1994, Pediatric Research.

[31]  Joan W. Miller,et al.  Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. , 1994, The American journal of pathology.

[32]  S. Udipi,et al.  Lipid peroxide levels in diabetics with micro- and macro-angiopathies , 1994 .

[33]  T. Nishino.  The conversion of xanthine dehydrogenase to xanthine oxidase and the role of the enzyme in reperfusion injury. , 1994, Journal of biochemistry.

[34]  A. P. Cullen.  OCULAR PATHOLOGY: A COLOR ATLAS, 2ND ED , 1994 .

[35]  M. Presta,et al.  Inhibition of angiogenesis in rats by IL-1 receptor antagonist and selected cytokine antibodies , 1994, Inflammation.

[36]  A. Ullrich,et al.  Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. , 1993, Cancer research.

[37]  E. Manseau,et al.  Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. , 1993, The American journal of pathology.

[38]  D. Faller,et al.  Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. , 1993, The Journal of clinical investigation.

[39]  W. Richardson,et al.  PDGF and its receptors in the developing rodent retina and optic nerve. , 1993, Development.

[40]  T. Gatanaga,et al.  Hypoxia induces a human macrophage cell line to release tumor necrosis factor-alpha and its soluble receptors in vitro. , 1993, The Journal of surgical research.

[41]  E. Keshet,et al.  Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis , 1992, Nature.

[42]  M. Lavail,et al.  Immunohistochemical localization of basic fibroblast growth factor in mature and developing retinas of normal and RCS rats. , 1992, Current eye research.

[43]  H. Hug,et al.  Platelet-derived growth factor-induced transcription of the vascular endothelial growth factor gene is mediated by protein kinase C. , 1992, Cancer research.

[44]  P. Chiba,et al.  Serum lipid peroxide levels in the course of coronary by-pass surgery. , 1992, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[45]  D. Armstrong,et al.  Relationship of lipid peroxides to diabetic complications. Comparison with conventional laboratory tests. , 1992, Journal of diabetes and its complications.

[46]  Harold E. Dvorak,et al.  Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels , 1991, The Journal of experimental medicine.

[47]  J. Folkman,et al.  Sustained-release endotoxin. A model for inducing corneal neovascularization. , 1991, Investigative ophthalmology & visual science.

[48]  P. Ghezzi,et al.  Hypoxia increases production of interleukin-1 and tumor necrosis factor by human mononuclear cells. , 1991, Cytokine.

[49]  C. Alessandri,et al.  Plasma thiobarbituric acid reactive substances a predictive marker of cerebral ischemia in patients at high risk? , 1991, Acta neurologica Scandinavica.

[50]  G. Brown,et al.  Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. , 1990, Archives of ophthalmology.

[51]  S. Snyder,et al.  Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[52]  C. Gajdusek,et al.  Injury‐induced release of basic fibroblast growth factor from bovine aortic endothelium , 1989, Journal of cellular physiology.

[53]  B. S. Fine,et al.  Ocular Pathology: A Color Atlas , 1987 .

[54]  D. Organisciak,et al.  The enzymatic estimation of organic hydroperoxides in the rat retina. , 1983, Experimental eye research.

[55]  D. Armstrong,et al.  Studies on experimentally induced retinal degeneration. 1. Effect of lipid peroxides on electroretinographic activity in the albino rabbit. , 1982, Experimental eye research.

[56]  D. Phelps,et al.  Vitamin E in kitten oxygen-induced retinopathy. II. Blockage of vitreal neovascularization. , 1979, Archives of ophthalmology.

[57]  N. Tolbert,et al.  A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. , 1978, Analytical biochemistry.

[58]  S. T. Adams.  RETINA AND OPTIC NERVE. , 1963, Archives of ophthalmology.

[59]  K. N. Sulochana,et al.  Eales' disease: accumulation of reactive oxygen intermediates and lipid peroxides and decrease of antioxidants causing inflammation, neovascularization and retinal damage. , 1997, Current eye research.

[60]  C. Pournaras,et al.  RETINAL OXYGEN DISTRIBUTION: Its Role in the Physiopathology of Vasoproliferative Microangiopathies , 1995, Retina.

[61]  J. Streilein,et al.  Immunological non-responsiveness and acquisition of tolerance in relation to immune privilege in the eye , 1995, Eye.

[62]  F. Grus,et al.  Indicators of oxidative tissue damage and inflammatory activity in epiretinal membranes of proliferative diabetic retinopathy, proliferative vitreoretinopathy and macular pucker. , 1995, German journal of ophthalmology.

[63]  J. Folkman,et al.  Hypoxic Induction of Endothelial Cell Growth Factors in Retinal Cells: Identification and Characterization of Vascular Endothelial Growth Factor (VEGF) as the Mitogen , 1995 .

[64]  R. Browne,et al.  The analysis of free radicals, lipid peroxides, antioxidant enzymes and compounds related to oxidative stress as applied to the clinical chemistry laboratory. , 1994, Advances in experimental medicine and biology.

[65]  J. Folkman,et al.  Increased Vascular Endothelial Growth Factor Levels in the Vitreous of Eyes With Proliferative Diabetic Retinopathy , 1995 .

[66]  E. Brogi,et al.  Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. , 1994, Circulation.

[67]  H. Gerlach,et al.  Relevance of tumour necrosis factor-alpha and interleukin-1-alpha in the pathogenesis of hypoxia-related organ failure. , 1993, European journal of anaesthesiology.

[68]  H. Gerlach,et al.  Relevance of tumour necrosis factor-α and interleukin-1-α in the pathogenesis of hypoxia-related organ failure , 1993 .

[69]  D. Organisciak,et al.  Intense-light mediated changes in rat rod outer segment lipids and proteins. , 1989, Progress in clinical and biological research.

[70]  E. Dratz,et al.  Lipid peroxide damage to the retina of albino rabbits. , 1989 .

[71]  H. Shepard,et al.  Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α , 1987, Nature.